Invictus MD prepares for legalization with expected cannabis ready production of 6,000 kg

Posted on Categories: Investor Relations

Vancouver, BC, October 27, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS1), through its interests in two Access to Cannabis for Medical Purposes Regulations (“ACMPR“) license holders, its wholly-owned subsidiary Acreage Pharms Ltd. (“Acreage Pharms”) and its one-third interest in AB Laboratories Inc. (“AB Labs”), expects to have production capacity of 6,000 kg commencing January 2018, several months before Canada expects cannabis to become recreationally legal. Total current production capacity at both locations is approximately 1,500 kg.

License Capacity and Term

Health Canada has removed the previously disclosed production capacity restrictions at both Acreage Pharms and AB Labs. In addition, AB Labs received an extension of its existing ACMPR license for a period of two years and Acreage Pharms’ ACMPR license was extended through to March 2020.

Read more “Invictus MD prepares for legalization with expected cannabis ready production of 6,000 kg”

Ottawa Makes Smart Move With Edibles

Posted on Categories: Knowledge CentreTags: , , , , , ,

We already know what Canadians are puffing —among others, we reportedly love the cannabis strains Romulan (created in British Columbia) and Lowryder, which thrives in cooler climates.

But soon, we will know what kinds of cannabis treats Canadians are nibbling, too.

In a pivot that we champion, Ottawa announced this month that it no longer plans to ban edible cannabis products from store shelves in Canada. We won’t see edibles until a year after recreational sales are legal, which is scheduled for July 1 of next year. But at least we are on the proper path.

Read more “Ottawa Makes Smart Move With Edibles”

Invictus MD Updates Shareholders on Cannabis Legalization Process

Posted on Categories: Investor Relations

Vancouver, BC, October 17, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS1) Today, Invictus MD updated shareholders that it is taking steps to monitor the government policy development process in advance of the legalization of recreational cannabis that is expected in July 2018.

“There are a number of authorities across the country that are developing policies and regulations to support the successful legalization of recreational cannabis. Invictus MD is monitoring these jurisdictions and will engage officials when necessary,” stated Dan Kriznic, Chairman and CEO of Invictus MD.

Read more “Invictus MD Updates Shareholders on Cannabis Legalization Process”